Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2009-11-04
Original SEC Filing: Click here

---

Webplus: SVA/20091104/6-K/2_EX-99.1/000.htm SEC Original: sinovacexh99_1.htm
It is anticipated that Sinovac’s common shares will commence trading on NASDAQ on or about November 16, 2009. Sinovac will continue to trade under the ticker symbol “SVA.” Mr. Weidong Yin, Chairman, President and CEO of Sinovac, stated, “The transfer of our stock listing to NASDAQ demonstrates our continued focus on creating shareholder value. We appreciate the support that the

---

---

Webplus: SVA/20091104/6-K/1/000.htm SEC Original: sinovac6k110309.htm
FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2009-11-04CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085